Page 82 - MI-2-2

Microbes & Immunity Biological activity of Amazonian plants

Plantas Amazônicas Utilizando como Modelo o Vírus da Mazzanti G. Antimicrobial triterpenoids from Licania
Imunodeficiência Símia. [Antiretroviral Activity Evaluation heteromorpha. Planta Med. 2000;66(8):768-769.
of Amazonian Plants Utilizing the Simian Immunodeficiency doi: 10.1055/s-2000-9601
Virus as a Model]. Dissertation. University of Brasilia;
2011. Available from: http://repositorio2.unb.br/jspui/ 42. Bilia AR, Mendez J, Morelli I. Phytochemical investigations
handle/10482/9185 [Last acessed on 2025 Jan 31]. of Licania genus. Flavonoids and triterpenoids from Licania
carii. Pharm Acta Helv. 1996a;71:191-197.
33. Tandon N, Yadav SS. Contributions of Indian Council of
Medical Research (ICMR) in the area of medicinal plants/ doi: 10.1016/0031-6865(96)00010-6
traditional medicine. J Ethnopharmacol. 2017;197:39-45. 43. Estrada O, Contreras W, Acha G, et al. Chemical constituents
doi: 10.1016/j.jep.2016.07.064 from Licania cruegeriana and their cardiovascular and
antiplatelet effects. Molecules. 2014;19(12):21215-21225.
34. Roux P, Alfieri C, Hrimech M, Cohen EA, Tanner JE.
Activation of transcription factors NF-kappaB and doi: 10.3390/molecules191221215
NF-IL-6 by human immunodeficiency virus type 1 44. Braca A, Sortino C, Mendez J, Morelli I. Triterpenes from
protein R (Vpr) induces interleukin-8 expression. J Virol. Licania licaniaeflora. Fitoterapia. 2001;72(5):585-587.
2000;74(10):4658-4665.
doi: 10.1016/s0367-326x(00)00321-x
doi: 10.1128/jvi.74.10.4658-4665.2000
45. Carvalho MG, Costa PM. Outros constituintes isolados de
35. Ellwanger JH, Valverde-Villegas JM, Kaminski VL, et al. Licania arianeae (Chrysobalanaceae) [Other constituents
Increased IL-8 levels in HIV-infected individuals who isolated from Licania arianeae (Chrysobalanaceae)]. Rev
initiated ART with CD4 T cell counts <350 cells/mm - A Bras Farmacogn. 2009;19(1b):290-293.
+
3
potential hallmark of chronic inflammation. Microbes Infect.
2020;22(9):474-480. doi: 10.1590/S0102-695X2009000200018
doi: 10.1016/j.micinf.2020.05.019 46. Fujioka T, Kashiwada Y, Kilkuskie RE, et al. Anti-AIDS
agents, 11. Betulinic acid and platanic acid as anti-HIV
36. Cummings MJ, Bakamutumaho B, Price A, et al. HIV principles from Syzigium claviflorum, and the anti-HIV
infection drives pro-inflammatory immunothrombotic activity of structurally related triterpenoids. J Nat Prod.
pathway activation and organ dysfunction among adults 1994;57(2):243-247.
with sepsis in Uganda. AIDS. 2023;37(2):233-245.
doi: 10.1021/np50104a008
doi: 10.1097/QAD.0000000000003410
47. Mayaux JF, Bousseau A, Pauwels R, et al. Triterpene
37. Dwivedi AK, Gornalusse GG, Siegel DA, et al. A cohort- derivatives that block entry of human immunodeficiency
based study of host gene expression: Tumor suppressor and virus type 1 into cells. Proc Natl Acad Sci U S A.
innate immune/inflammatory pathways associated with the 1994;91(9):3564-3568.
HIV reservoir size. PLoS Pathog. 2023;19(11):e1011114.
doi: 10.1073/pnas.91.9.3564
doi: 10.1371/journal.ppat.1011114
48. Hashimoto F, Kashiwada Y, Cosentino LM, Chen CH,
38. Schonhofer C, Yi J, Sciorillo A, et al. Flavonoid-based Garrett PE, Lee KH. Anti-AIDS agents--XXVII. Synthesis
inhibition of cyclin-dependent kinase 9 without concomitant and anti-HIV activity of betulinic acid and dihydrobetulinic
inhibition of histone deacetylases durably reinforces HIV acid derivatives. Bioorg Med Chem. 1997;5(12):2133-2143.
latency. Biochem Pharmacol. 2021;186:114462.
doi: 10.1016/s0968-0896(97)00158-2
doi: 10.1016/j.bcp.2021.114462
49. Aiken C, Chen CH. Betulinic acid derivatives as HIV-1
39. Ka’e AC, Nanfack AJ, Ambada G, et al. Inflammatory profile antivirals. Trends Mol Med. 2005;11(1):31-36.
of vertically HIV-1 infected adolescents receiving ART in
Cameroon: A contribution toward optimal pediatric HIV doi: 10.1016/j.molmed.2004.11.001
control strategies. Front Immunol. 2023;14:1239877. 50. Than NN, Fotso S, Poeggeler B, Hardeland R, Laatsch H.
doi: 10.3389/fimmu.2023.1239877 Niruriflavone, a new antioxidant flavone sulfonic acid from
Phyllanthus niruri. ChemInform. 2006;67(1):1-4.
40. Fernandes J, Castilho RO, da Costa MR, Wagner-Souza K,
Coelho Kaplan MA, Gattass CR. Pentacyclic triterpenes doi: 10.1002/chin.200625196
from Chrysobalanaceae species: Cytotoxicity on multidrug 51. Moore PS, Pizza C. Observations on the inhibition of HIV-1
resistant and sensitive leukemia cell lines. Cancer Lett. reverse transcriptase by catechins. Biochem J. 1992;288 (Pt
2003;190(2):165-169. 3):717-719.
doi: 10.1016/s0304-3835(02)00593-1 doi: 10.1042/bj2880717
41. Braca A, Morelli I, Mendez J, Battinelli L, Braghiroli L, 52. Hussein G, Miyashiro H, Nakamura N, et al. Inhibitory

Volume 2 Issue 2 (2025) 74 doi: 10.36922/mi.8367